Chronic Toxicity and Carcinogenic Potential of Tris-(1,3-Dichloro-2-propyl) Phosphate in Sprague-Dawley Rat
Authors:
- 1 March 2000
- journal article
- research article
- Published by SAGE Publications in International Journal of Toxicology
- Vol. 19 (2) , 119-125
Abstract
The Flammable Fabrics Act of 1953 and its amendments established a need for flame-resistant fabrics. Tris-(1,3-dichloro-2-propyl) phosphate (TDCPP) was briefly used in apparel fabrics to assist in the compliance with federal flammability standards, and continues to be used as a flame retardant in flexible polyurethane foams. A chronic toxicity and carcinogenicity bioassay was conducted in Sprague-Dawley rats to determine the toxicologic and carcinogenic potential of TDCPP after repeated exposure. Four groups of animals, each consisting of 60 male and 60 female rats, received via their diet a daily dose of either 0, 5, 20, or 80 mg TDCPP per kg body weight for up to 24 months. Diets were adjusted after each weekly (first 13 weeks) or biweekly (weeks 14 through 104) body weight and food consumption measurement to achieve and maintain the indicated doses. Ten animals per sex were taken from each group for interim sacrifice at the end of the 12th month. Body weights, food consumption, clinical signs, and hematological and clinical chemistry parameters were measured periodically, and ophthalmoscopic examinations were conducted on all animals. After complete postmortem examination of all animals, microscopic examination of all tissues was conducted for the control and high-dose animals. Liver, kidneys, testes, and adrenal glands were examined from all animals. Mortality was significantly higher and body weights were significantly lower in the high-dose group when compared to control animals. Certain hematology parameters, such as hemoglobin, hematocrit, and total erythrocyte values, were decreased in the high-dose animals. Ophthalmoscope examination revealed no treatment-related changes. Microscopic examination revealed a higher incidence of benign neoplasms and non-neoplastic alterations in several organs of the mid and high dose animals. The no-observed-adverse-effect level (NOAEL) for chronic toxicity and neoplastic activity was the dietary dose of 5 mg/kg/day.Keywords
This publication has 11 references indexed in Scilit:
- Metabolic Activation of Tris(2,3-dibromopropyl)phosphate to Reactive Intermediates. I. Covalent Binding and Reactive Metabolite Formation in VitroToxicology and Applied Pharmacology, 1993
- Target organs in chronic bioassays of 533 chemical carcinogens.Environmental Health Perspectives, 1991
- The Effects of Tris(2,3-Dibromopropyl)Phosphate on the Reproductive System of Male RatsJournal of the American College of Toxicology, 1986
- Unscheduled DNA synthesis of rat hepatocytes in monolayer cultureMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1984
- Comparative genotoxicity studies of the flame retardant tris(2,3-dibromopropyl)phosphate and possible metabolitesMutation Research/Genetic Toxicology, 1983
- The metabolism and disposition of tris(1,3-dichloro-2-propyl) phosphate (fyrol FR-2) in the ratToxicology and Applied Pharmacology, 1981
- Children Absorb Tris-BP Flame Retardant from Sleepwear: Urine Contains the Mutagenic Metabolite, 2,3-DibromopropanolScience, 1978
- Renal and testicular damage following dermal application of the flame retardant tris(2,3‐dibromopropyl) phosphateJournal of Toxicology and Environmental Health, 1977
- Tris(2,3-Dibromopropyl) Phosphate: Mutagenicity of a Widely Used Flame RetardantScience, 1977
- New Tables for Multiple Comparisons with a ControlBiometrics, 1964